Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Daniel Lochner (Chief Financial Officer): Tax Withholding of 520 shares, $12.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Daniel Lochner, Chief Financial Officer | Tax Withholding | 520 | $12.3K |
| Oct 2, 2026 | Peter McNamara, Chief Scientific Officer | Tax Withholding | 444 | $10.5K |
| Oct 2, 2026 | Marcella K. Ruddy, Chief Medical Officer | Tax Withholding | 525 | $12.4K |
| Oct 2, 2026 | Alise Reicin, Chief Executive Officer | Tax Withholding | 1,545 | $36.6K |
| Oct 2, 2026 | Marc Schwabish, Chief Business Officer | Tax Withholding | 411 | $9.7K |
| Sep 8, 2026 | Marc Schwabish, Chief Business Officer | Grant/Award | 17,750 | n/a |
| Sep 8, 2026 | Peter McNamara, Chief Scientific Officer | Grant/Award | 21,000 | n/a |
| Sep 8, 2026 | Daniel Lochner, Chief Financial Officer | Grant/Award | 24,250 | n/a |
| Sep 8, 2026 | Marcella K. Ruddy, Chief Medical Officer | Grant/Award | 24,250 | n/a |
| Sep 8, 2026 | Alise Reicin, Chief Executive Officer | Grant/Award | 69,250 | n/a |